MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR), Mesoblast (NASDAQ:MESO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
MannKind has a consensus price target of $8.56.
The stock price for MannKind (NASDAQ: MNKD) is $6.1001 last updated January 22, 2025 at 6:58 PM EST.
There are no upcoming dividends for MannKind.
MannKind’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.